Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
Pietroboni AM, Schiano di Cola F, Scarioni M, Fenoglio C, Spanò B, Arighi A, Cioffi SM, Oldoni E, De Riz MA, Basilico P, Calvi A, Fumagalli GG, Triulzi F, Galimberti D, Bozzali M, Scarpini E. Pietroboni AM, et al. Among authors: scarioni m. Mult Scler. 2017 Jul;23(8):1085-1091. doi: 10.1177/1352458516674566. Epub 2016 Oct 17. Mult Scler. 2017. PMID: 27754941
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.
Pietroboni AM, Dell'Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, Ghezzi L, Fumagalli GG, De Riz MA, Basilico P, Colombi A, Benatti E, Triulzi F, Scarpini E, Viola F, Galimberti D. Pietroboni AM, et al. Among authors: scarioni m. Mult Scler. 2019 Jan;25(1):31-38. doi: 10.1177/1352458517740214. Epub 2017 Nov 10. Mult Scler. 2019. PMID: 29125019 Free article.
CSF β-amyloid predicts prognosis in patients with multiple sclerosis.
Pietroboni AM, Caprioli M, Carandini T, Scarioni M, Ghezzi L, Arighi A, Cioffi S, Cinnante C, Fenoglio C, Oldoni E, De Riz MA, Basilico P, Fumagalli GG, Colombi A, Giulietti G, Serra L, Triulzi F, Bozzali M, Scarpini E, Galimberti D. Pietroboni AM, et al. Among authors: scarioni m. Mult Scler. 2019 Aug;25(9):1223-1231. doi: 10.1177/1352458518791709. Epub 2018 Aug 7. Mult Scler. 2019. PMID: 30084711 Free article.
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G. Pietroboni AM, et al. Among authors: scarioni m. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):280-287. doi: 10.1007/s00259-018-4182-1. Epub 2018 Oct 21. Eur J Nucl Med Mol Imaging. 2019. PMID: 30343433
CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.
Pietroboni AM, Scarioni M, Carandini T, Basilico P, Cadioli M, Giulietti G, Arighi A, Caprioli M, Serra L, Sina C, Fenoglio C, Ghezzi L, Fumagalli GG, De Riz MA, Calvi A, Triulzi F, Bozzali M, Scarpini E, Galimberti D. Pietroboni AM, et al. Among authors: scarioni m. J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):352-357. doi: 10.1136/jnnp-2017-316603. Epub 2017 Oct 20. J Neurol Neurosurg Psychiatry. 2018. PMID: 29054920
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation.
Ghezzi L, Carandini T, Arighi A, Fenoglio C, Arcaro M, De Riz M, Pietroboni AM, Fumagalli GG, Basilico P, Calvi A, Scarioni M, Colombi A, Serpente M, Marotta G, Benti R, Scarpini E, Galimberti D. Ghezzi L, et al. Among authors: scarioni m. Neurology. 2017 Dec 12;89(24):2503-2505. doi: 10.1212/WNL.0000000000004747. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142083 No abstract available.
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
Arighi A, Di Cristofori A, Fenoglio C, Borsa S, D'Anca M, Fumagalli GG, Locatelli M, Carrabba G, Pietroboni AM, Ghezzi L, Carandini T, Colombi A, Scarioni M, De Riz MA, Serpente M, Rampini PM, Scarpini E, Galimberti D. Arighi A, et al. Among authors: scarioni m. J Alzheimers Dis. 2019;69(3):663-669. doi: 10.3233/JAD-190119. J Alzheimers Dis. 2019. PMID: 31156164
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
Carandini T, Arighi A, Sacchi L, Fumagalli GG, Pietroboni AM, Ghezzi L, Colombi A, Scarioni M, Fenoglio C, De Riz MA, Marotta G, Scarpini E, Galimberti D. Carandini T, et al. Among authors: scarioni m. Alzheimers Res Ther. 2019 Oct 15;11(1):84. doi: 10.1186/s13195-019-0543-7. Alzheimers Res Ther. 2019. PMID: 31615545 Free PMC article.
34 results